Neurology devices are specialized surgical devices used for the treatment of disease or conditions of the central nervous system (CNS) and spine. Hydrocephalus shunts allow excess cerebrospinal fluid (CSF) to drain to another area of the body. GlobalData uses proprietary data and analytics to provide a comprehensive report on the hydrocephalus shunts market in Italy. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the hydrocephalus shunts market in Italy was Integra LifeSciences followed by Medtronic, Natus Medical, Sophysa and Spiegelberg.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Hydrocephalus valves and hydrocephalus catheters are covered in this category. Hydrocephalus valves regulate the flow of CSF out of the brain’s ventricles. Two types of hydrocephalus catheters are considered in the market: antimicrobial catheters and standard catheters.
The hydrocephalus shunts market in Italy can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size hydrocephalus shunts in Italy, buy the report here.